Successive motor nerve blocks to identify the muscles causing a spasticity pattern: example of the arm flexion...

Area of Science:

• Neuroscience
• Rehabilitation Medicine
• Anatomy

Background:

• Botulinum Toxin A has been a primary treatment for spasticity since the early 1990s.
• Current treatment lacks consensus on injection parameters and optimal muscle targeting for functional improvement.
• The arm flexion pattern in spasticity presents a challenge for effective treatment.

Purpose of the Study:

• To develop a systematic approach for identifying target muscles for Botulinum Toxin A injections.
• To specifically address the arm flexion pattern in patients with spasticity.
• To enhance the effectiveness of Botulinum Toxin A therapy through precise muscle targeting.

Main Methods:

• Anatomical dissection of 20 forearms to identify landmarks for selective motor nerve blocks.
• Selective nerve blocks of brachialis, brachioradialis, and biceps brachii in stroke patients with arm flexion spasticity.
• Measurement of elbow resting angle, active/passive range of extension, and spasticity using standardized scales.

Main Results:

• Inhibiting the brachialis nerve significantly decreased the elbow resting angle and improved passive extension.
• Sequential nerve blocks demonstrated that brachialis is the primary muscle limiting elbow extension in the arm flexion pattern.
• Targeting brachialis, rather than just superficial or powerful muscles, is crucial for effective spasticity management.

Conclusions:

• A systematic approach to muscle selection is essential for optimizing Botulinum Toxin A efficacy in spasticity.
• The brachialis muscle should be the principal target for improving the arm flexion pattern.
• Comprehensive patient assessment is required to ensure relevant muscles are targeted for improved functional outcomes.